Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maysa Sarhan"'
Publikováno v:
Complementary Medicine Research.
Introduction: Autoimmune bullous diseases (AIBD) are a heterogeneous group of rare autoantibody mediated blistering dermatoses of the skin and/ or mucous membranes. Their incidence is around 20 new cases per million inhabitants per year in Germany. P
Autor:
Valentin al Jalali, Martin Bauer, Michael Wölfl-Duchek, Maysa Sarhan, Sebastian G. Wicha, Stefan Poschner, Walter Jäger, Franz König, Christoph Male, Markus Zeitlinger
Publikováno v:
Clinical pharmacokinetics.
Exhaustive pharmacokinetic (PK) studies in paediatric patients are unavailable for most antibiotics and feasibility of PK studies is limited by challenges, such as low blood volume and venipuncture-related pain. Microdialysis (MD) represents a promis
Publikováno v:
Physiological reviews. 98(2)
When cells undergo necrotic cell death in either physiological or pathophysiological settings in vivo, they release highly immunogenic intracellular molecules and organelles into the interstitium and thereby represent the strongest known trigger of t
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 2, Pp 1-15 (2018)
Cell Death and Disease, Vol 9, Iss 2, Pp 1-15 (2018)
Death of renal cells is central to the pathophysiology of acute tubular necrosis, autoimmunity, necrotizing glomerulonephritis, cystic kidney disease, urosepsis, delayed graft function and transplant rejection. By means of regulated necrosis, immunog
Autor:
Ralph J. DiLeone, David M Grimaldi, Douglas J. Guarnieri, Maysa Sarhan, Nandakumar S. Narayanan, Karl Deisseroth, Rong-Jian Liu, Catherine E. Brayton, Carol A. Gianessi, Benjamin B. Land, George K. Aghajanian
Publikováno v:
Nature neuroscience
Although the prefrontal cortex influences motivated behavior, its role in food intake remains unclear. Here, we demonstrate a role for D1-type dopamine receptor-expressing neurons in the medial prefrontal cortex (mPFC) in the regulation of feeding. F
Autor:
Hugues Dardente, Pierre Veinante, Venetia Zachariou, Ralph J. DiLeone, Florent Barthas, Maysa Sarhan, Jennifer Kaufling, Sophie A. Pawlowski, Ipek Yalcin, Michel Barrot
Publikováno v:
International Journal of Neuropsychopharmacology
International Journal of Neuropsychopharmacology, Oxford University Press (OUP), 2013, 16 (7), pp.1649-1660. ⟨10.1017/S146114571200168X⟩
International Journal of Neuropsychopharmacology, Oxford University Press (OUP), 2013, 16 (7), pp.1649-1660. ⟨10.1017/S146114571200168X⟩
In addition to its neurotrophic role, brain-derived neurotrophic factor (BDNF) is involved in a wide array of functions, including anxiety and pain. The central amygdaloid nucleus (CeA) contains a high concentration of BDNF in terminals, originating
Publikováno v:
Brain Research. 1314:130-138
The orexins (or hypocretins) are hypothalamic neuropeptides that have been implicated in a variety of behaviors ranging from feeding to sleep and arousal. Evidence from animal models suggests a role for orexins in reward processing and drug addiction
Autor:
Constanza Dalvit, A. Benoilid, Jerome Aupy, Maria-Paola Valenti, Maysa Sarhan, Edouard Hirsch
Publikováno v:
Epileptic disorders : international epilepsy journal with videotape. 15(1)
Epilepsy is a common disorder but diagnosis remains largely clinical. Although MRI and EEG significantly aid the diagnosis of epilepsy, these techniques may also be misleading and indicate abnormalities not related to phenomenology. Consequences of e
Publikováno v:
Narcolepsy ISBN: 9781441983893
The hypothalamic neuropeptide orexin (hypocretin) influences a range of behaviors ranging from feeding to sleep and arousal. While genetic studies in rodents first demonstrated a role of orexin in narcolepsy with cataplexy, more recent work has broug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b665567ed801b97152c9077a529f65c
https://doi.org/10.1007/978-1-4419-8390-9_23
https://doi.org/10.1007/978-1-4419-8390-9_23
Autor:
Maysa Sarhan, Samuel S. Newton, Vanja Duric, Matthew J. Girgenti, Hideki Okamoto, Ronald S. Duman, Mounira Banasr, Ralph J. DiLeone, Bhavya Voleti
Background Despite recent interest in glycogen synthase kinase-3β (GSK-3β) as a target for the treatment of mood disorders, there has been very little work related to these illnesses on the upstream signaling molecules that regulate this kinase as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00859d28c9bd074e96fa427c9e0ad52f
https://europepmc.org/articles/PMC2929274/
https://europepmc.org/articles/PMC2929274/